416 SOT Flashcards
Depleting agents for indication therapy
ATGAM
RATG
Alemtuzumab
Non-depleting agent for induction therapy
Basiliximab
MOA of antithymocytes (RATG, ATGAM)
Action against T and B cells
-apoptosis (release cytokines=premedicate)
RATG (Thymoglobulin) dosing
1-1.5 mg/kg given over 4-6hrs (round to nearest 25mg due to vial size)
AE of RATG
- leukopenia (hold therapy when WBC <3000)
- thrombocytopenia
- fever, chills, malaise, tachycardia
MOA of Alemtuzumab
CD52 antagonist
Alemtuzumab dosing
30mg SQ x1 prep
AE Alemtuzumab
Fever, chills, arthralgia, hypotension
-SQ decreases hypotension
MOA of Basiliximab
IL-2 receptor antagonist- prevents activation of IL-2 receptors
Dosing of Basiliximab
20mg IV within 2hrs prior to surgery then 20mg IV 3-4days after
Corticosteroids for induction therapy
Methylprednisolone 3mg/kg (or 1GM)
Antimicrobial prophylaxis for liver transplant
Unasyn 3g q6h for 24hrs
Antimicrobial prophylaxis for liver/small bowel
Zosyn 4.5g q6h for 24hrs
Antimicrobial prophylaxis for kidney OR heart
Cefazolin 1-2g q8h for 24hrs
Antimicrobial prophylaxis for kidney/pancreas
Cefoxitin 1-2g q8h for 24hrs
VTE prophylaxis
Heparin 5000 units SQ q8h OR
Lovenox 40mg SQ QD
Cyclosporine brand names for maintenance therapy
Sandimmune
Neoral
DO NOT switch
MOA of cyclosporine
Calcineurin inhibitor that inhibits secretion of IL-2
-inhibits T cell activation and proliferation
Tacrolimus brand names for maintenance therapy
Prograf
FK